Statistical methods in oncology trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
Hazard ratio
Log-rank test
Cochran-Mantel-Haenszel test
Odds ratio
Cox proportional-hazards model
Fisher exact test
Risk difference
Stratified log-rank test
All oncology trials
2,067 results
- Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer: primary endpoint results, effect estimate with confidence…
- Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin’s Lymphoma (NHL) Weighing Less Than 70 Kilograms: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms: primary endpoint results, effect estimate with…
- Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00985829).
- Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02483416).
- Evaluations of Alcohol Warning Labels: Complete Statistical AnalysisIndependent statistical analysis of Evaluations of Alcohol Warning Labels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06129487).
- EVERESTIndependent statistical analysis of the phase 3 EVEREST trial of everolimus in combination with cyclosporine microemulsion in de novo renal transplant recipients, including trial design, endpoints, planned statistical methods, reported safety events,…
- Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Everolimus for Cancer With TSC1 or TSC2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Cancer With TSC1 or TSC2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201212).
- Everolimus for Children With Recurrent or Progressive Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Children With Recurrent or Progressive Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155920).
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evolut EXPANDAn educational statistical analysis of the randomized Evolut EXPAND trial evaluating Medtronic Evolut TAVR systems with guideline-directed management and therapy in moderate aortic valve stenosis.
- Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: primary endpoint results, effect estimate with…
- Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- eXalt3Independent statistical analysis of the phase 3 eXalt3 trial comparing ensartinib with crizotinib in ALK-positive non-small cell lung cancer, including trial design, progression-free survival methodology, interpretation, and statistical limitations.
- EXAMINERIndependent statistical analysis of A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ExCelA complete statistical analysis of the ExCel phase 3 trial of exemestane for breast cancer prevention in postmenopausal women at increased risk, including trial design, breast cancer-free survival, hazard ratios, confidence intervals,…
- ExCeLIndependent statistical analysis of EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810797).
- Exercise and QUality Diet After Leukemia: The EQUAL Study: Complete Statistical AnalysisIndependent statistical analysis of Exercise and QUality Diet After Leukemia: The EQUAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02244411).
- Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: Complete Statistical AnalysisIndependent statistical analysis of Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: primary endpoint results,…
- EXTAXIndependent statistical analysis of Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- EXTENDIndependent statistical analysis of Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02725528).
- ExteNETIndependent statistical analysis of the phase 3 ExteNET trial of neratinib after adjuvant trastuzumab in women with early stage breast cancer, including randomized design, time-to-event endpoints, hazard ratios, confidence intervals, survival methodology,…
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study of IMO-8400 in Patients With Waldenström’s Macroglobulinemia Who Completed Study 8400-401: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038): Complete Statistical AnalysisIndependent statistical analysis of Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- F-18 Sodium Fluoride in Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of F-18 Sodium Fluoride in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240551).
- FACEIndependent statistical analysis of the FACE phase 3 trial comparing letrozole with anastrozole in the adjuvant treatment of postmenopausal women with hormone receptor and node positive breast cancer.
- Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation: Complete Statistical AnalysisIndependent statistical analysis of Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04683744).
- FAKTIONIndependent statistical analysis of the FAKTION randomized phase 1/2 trial of fulvestrant with AZD5363 versus fulvestrant-based treatment in estrogen receptor positive breast cancer. Includes trial design, endpoints, planned statistical analysis, and interpretation…
- FANG-CLMIndependent statistical analysis of Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FAPESTIndependent statistical analysis of A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FAST-ForwardA statistical analysis of the FAST-Forward randomized clinical trial evaluating radiotherapy-related early side effects in breast cancer using the EORTC QLQ-BR23 questionnaire. Includes trial design, endpoints, planned methodology, and statistical interpretation.
- Fast-track Rehabilitation After Elective Colorectal and Small Bowel Resection: Complete Statistical AnalysisIndependent statistical analysis of Fast-track Rehabilitation After Elective Colorectal and Small Bowel Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00606944).
- Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients: Complete Statistical AnalysisIndependent statistical analysis of Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers: primary endpoint results, effect estimate with…
- Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…